Biomaterials developed for tissue engineering and wound healing application
s need to support robust cell adhesion, yet also need to be replaced by new
tissue synthesized by those cells. In order to maintain mechanical integri
ty of the tissue, the cells must generate sufficient extracellular matrix b
efore the scaffold is degraded. We have previously shown that materials con
taining cell adhesive ligands to promote or improve cell adhesion can decre
ase extracellular matrix production (Mann et al.. Modification of surfaces
with cell adhesion peptides alters extracellular matrix deposition. Biomate
rials 1999:20:2281-6). Such decreased matrix production by cells in tissue
engineering scaffolds may result in tissue failure. However. we have found
that TGF-beta1 can be used in scaffolds to dramatically increase matrix pro
duction. Matrix production by vascular smooth muscle cells grown on adhesiv
e ligand-modified glass surfaces and in PEG hydrogels containing covalently
bound adhesive ligands was increased in the presence of 0.04 pmol/ml (1 ng
/ml) TGF-beta1, TGF-beta1 can counteract the effect of these adhesive ligan
ds on matrix production; matrix production could be increased even above th
at observed in the absence of adhesive peptides. Further, TGF-beta1 covalen
tly immobilized to PEG retained its ability to increase matrix production.
Tethering TGF-beta1 to the polymer scaffold resulted in a significant incre
ase in matrix production over the same amount of soluble TGF-beta1. (C) 200
1 Elsevier Science Ltd. All rights reserved.